FDA Drug Application (075091) for CARBIDOPA AND LEVODOPA by MYLAN

Back to FDA Applications sponsored by MYLAN

Application Number075091
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage50MG;200MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCARBIDOPA AND LEVODOPA
Active IngredientCARBIDOPA; LEVODOPA

Active IngredientCount
List of drugs with Active Ingredient CARBIDOPA16
List of drugs with Active Ingredient LEVODOPA17


Back to FDA Applications sponsored by MYLAN